268 related articles for article (PubMed ID: 32250304)
41. Assessing out-of-pocket expenses and indirect costs for the Alzheimer disease continuum in the United States.
Monfared AAT; Hummel N; Chandak A; Khachatryan A; Zhang Q
J Manag Care Spec Pharm; 2023 Sep; 29(9):1065-1077. PubMed ID: 37307097
[No Abstract] [Full Text] [Related]
42. Health-related resource use and costs in elderly adults with and without mild cognitive impairment.
Zhu CW; Sano M; Ferris SH; Whitehouse PJ; Patterson MB; Aisen PS
J Am Geriatr Soc; 2013 Mar; 61(3):396-402. PubMed ID: 23414481
[TBL] [Abstract][Full Text] [Related]
43. Disease Progression in Mild Dementia due to Alzheimer Disease in an 18-Month Observational Study (GERAS): The Impact on Costs and Caregiver Outcomes.
Jones RW; Lebrec J; Kahle-Wrobleski K; Dell'Agnello G; Bruno G; Vellas B; Argimon JM; Dodel R; Haro JM; Wimo A; Reed C
Dement Geriatr Cogn Dis Extra; 2017; 7(1):87-100. PubMed ID: 28611822
[TBL] [Abstract][Full Text] [Related]
44. [Cost relation between severity of Alzheimer's disease and cognitive and functional impairment].
López-Pousa S; Garre-Olmo J; Turon-Estrada A; Hernández F; Expósito I; Lozano-Gallego M; Hernández-Ferrándiz M; Gelada-Batlle E; Pericot-Nierga I; Vilalta-Franch J
Med Clin (Barc); 2004 May; 122(20):767-72. PubMed ID: 15207104
[TBL] [Abstract][Full Text] [Related]
45. Severity Distribution of Alzheimer's Disease Dementia and Mild Cognitive Impairment in the Framingham Heart Study.
Yuan J; Maserejian N; Liu Y; Devine S; Gillis C; Massaro J; Au R
J Alzheimers Dis; 2021; 79(2):807-817. PubMed ID: 33361590
[TBL] [Abstract][Full Text] [Related]
46. How to deal with missing longitudinal data in cost of illness analysis in Alzheimer's disease-suggestions from the GERAS observational study.
Belger M; Haro JM; Reed C; Happich M; Kahle-Wrobleski K; Argimon JM; Bruno G; Dodel R; Jones RW; Vellas B; Wimo A
BMC Med Res Methodol; 2016 Jul; 16():83. PubMed ID: 27430559
[TBL] [Abstract][Full Text] [Related]
47. Neuropsychiatric symptoms and executive functioning in patients with mild cognitive impairment: relationship to caregiver burden.
Ryan KA; Weldon A; Persad C; Heidebrink JL; Barbas N; Giordani B
Dement Geriatr Cogn Disord; 2012; 34(3-4):206-15. PubMed ID: 23128102
[TBL] [Abstract][Full Text] [Related]
48. A Real-World Evidence Analysis of Associations Among Costs, Quality of Life, and Disease-Severity Indicators of Alzheimer's Disease in Thailand.
Kongpakwattana K; Dejthevaporn C; Krairit O; Dilokthornsakul P; Mohan D; Chaiyakunapruk N
Value Health; 2019 Oct; 22(10):1137-1145. PubMed ID: 31563256
[TBL] [Abstract][Full Text] [Related]
49. The clinical and economic burden among caregivers of patients with Alzheimer's disease in Canada.
Szabo S; Lakzadeh P; Cline S; Palma Dos Reis R; Petrella R
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1677-1688. PubMed ID: 31353572
[TBL] [Abstract][Full Text] [Related]
50. Cost and care of patients with Alzheimer's disease: clinical predictors in German health care settings.
Reese JP; Hessmann P; Seeberg G; Henkel D; Hirzmann P; Rieke J; Baum E; Dannhoff F; Müller MJ; Jessen F; Geldsetzer MB; Dodel R
J Alzheimers Dis; 2011; 27(4):723-36. PubMed ID: 21876256
[TBL] [Abstract][Full Text] [Related]
51. The effects of patient function and dependence on costs of care in Alzheimer's disease.
Zhu CW; Leibman C; McLaughlin T; Scarmeas N; Albert M; Brandt J; Blacker D; Sano M; Stern Y
J Am Geriatr Soc; 2008 Aug; 56(8):1497-503. PubMed ID: 18662215
[TBL] [Abstract][Full Text] [Related]
52. Medical Journey of Patients with Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia: A Cross-sectional Survey of Patients, Care Partners, and Neurologists.
Pruzin JJ; Brunton S; Alford S; Hamersky C; Sabharwal A; Gopalakrishna G
J Prev Alzheimers Dis; 2023; 10(2):162-170. PubMed ID: 36946442
[TBL] [Abstract][Full Text] [Related]
53. Financial Management Skills in Aging, MCI and Dementia: Cross Sectional Relationship to 18F-Florbetapir PET Cortical β-amyloid Deposition.
Tolbert S; Liu Y; Hellegers C; Petrella JR; Weiner MW; Wong TZ; Murali Doraiswamy P
J Prev Alzheimers Dis; 2019; 6(4):274-282. PubMed ID: 31686100
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.
Feldman H; Gauthier S; Hecker J; Vellas B; Emir B; Mastey V; Subbiah P;
J Am Geriatr Soc; 2003 Jun; 51(6):737-44. PubMed ID: 12757558
[TBL] [Abstract][Full Text] [Related]
55. Household members of persons with Alzheimer's disease: health conditions, healthcare resource use, and healthcare costs.
Suehs BT; Shah SN; Davis CD; Alvir J; Faison WE; Patel NC; van Amerongen D; Bobula J
J Am Geriatr Soc; 2014 Mar; 62(3):435-41. PubMed ID: 24576203
[TBL] [Abstract][Full Text] [Related]
56. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
57. The cost of Alzheimer's disease in managed care: a cross-sectional study.
Leon J; Neumann PJ
Am J Manag Care; 1999 Jul; 5(7):867-77. PubMed ID: 10557408
[TBL] [Abstract][Full Text] [Related]
58. Caregiver rating bias in mild cognitive impairment and mild Alzheimer's disease: impact of caregiver burden and depression on dyadic rating discrepancy across domains.
Pfeifer L; Drobetz R; Fankhauser S; Mortby ME; Maercker A; Forstmeier S
Int Psychogeriatr; 2013 Aug; 25(8):1345-55. PubMed ID: 23651733
[TBL] [Abstract][Full Text] [Related]
59. Economic evaluation of donepezil in moderate to severe Alzheimer disease.
Feldman H; Gauthier S; Hecker J; Vellas B; Hux M; Xu Y; Schwam EM; Shah S; Mastey V;
Neurology; 2004 Aug; 63(4):644-50. PubMed ID: 15326236
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
